Putting Science to Work

In Focus

infd
Syngene eyes capacity and capability expansion post-IPO

Outsourcing Pharma-21/10/2015. Syngene says it will invest in new capacity and capabilities, including a viral testing facility, as it reports strong results in its first quarter post-IPO.

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

FB Side
Inactive